Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
Live-Imaging in the CNS: New Insights on Oligodendrocytes, Myelination, and their Responses to Inflammation.
[Treatment of transplantation of NT-3 gene modified olfactory ensheathing cells on experimental autoimmune encephalomyelitis in rats].
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.
Can vitamin d suppress endothelial cells apoptosis in multiple sclerosis patients?
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
Quality of life and employment in persons with multiple sclerosis.
RECENT ADVANCES IN MESENCHYMAL STEM CELL IMMUNOMODULATION. THE ROLE OF MICROVESICLES.
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
[Treatment of multiple sclerosis symptoms and exacerbations].
DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients.
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
CX3CR1 in multiple sclerosis.
Isolated cognitive relapses in multiple sclerosis.
Characterizing cognitive function during relapse in multiple sclerosis.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
Multiple sclerosis lesion segmentation using dictionary learning and sparse coding.
Pages
« first
‹ previous
…
391
392
393
394
395
396
397
398
399
…
next ›
last »